Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model.

OBJECTIVE Stromal cell-derived factor 1 (SDF-1; CXCL12/pre-B cell growth-stimulating factor) is a dominant chemokine in bone marrow and is known to be involved in inflammatory diseases, including rheumatoid arthritis. However, its role in bone repair remains unknown. The purpose of this study was to investigate the role of SDF-1 and its receptor, CXCR4, in bone healing. METHODS The expression of SDF-1 during the repair of a murine structural femoral bone graft was examined by real-time polymerase chain reaction and immunohistochemical analysis. The bone graft model was treated with anti-SDF-1 neutralizing antibody or TF14016, an antagonist for CXCR4, and evaluated by histomorphometry. The functional effect of SDF-1 on primary mesenchymal stem cells was determined by in vitro and in vivo migration assays. New bone formation in an exchanging-graft model was compared with that in the autograft models, using mice partially lacking SDF-1 (SDF-1(+/-)) or CXCR4 (CXCR4(+/-)). RESULTS The expression of SDF1 messenger RNA was increased during the healing of live bone grafts but was not increased in dead grafts. High expression of SDF-1 protein was observed in the periosteum of the live graft. New bone formation was inhibited by the administration of anti-SDF-1 antibody or TF14016. SDF-1 increased mesenchymal stem cell chemotaxis in vitro in a dose-dependent manner. The in vivo migration study demonstrated that mesenchymal stem cells recruited by SDF-1 participate in endochondral bone repair. Bone formation was decreased in SDF-1(+/-) and CXCR4(+/-) mice and was restored by the graft bones from CXCR4(+/-) mice transplanted into the SDF-1(+/-) femur, but not vice versa. CONCLUSION SDF-1 is induced in the periosteum of injured bone and promotes endochondral bone repair by recruiting mesenchymal stem cells to the site of injury.

[1]  Ken Kumagai,et al.  Circulating cells with osteogenic potential are physiologically mobilized into the fracture healing site in the parabiotic mice model , 2008, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[2]  Hideki Yoshikawa,et al.  Circulating Bone Marrow‐Derived Osteoblast Progenitor Cells Are Recruited to the Bone‐Forming Site by the CXCR4/Stromal Cell‐Derived Factor‐1 Pathway , 2008, Stem cells.

[3]  Robert E Guldberg,et al.  Recent advances in gene delivery for structural bone allografts. , 2007, Tissue engineering.

[4]  Antonios G Mikos,et al.  Pre-culture period of mesenchymal stem cells in osteogenic media influences their in vivo bone forming potential. , 2007, Journal of biomedical materials research. Part A.

[5]  M. Ratajczak,et al.  Stem cells as a two edged sword--from regeneration to tumor formation. , 2006, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[6]  M. Ratajczak,et al.  Physiological and pathological consequences of identification of very small embryonic like (VSEL) stem cells in adult bone marrow. , 2006, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[7]  J. Toguchida,et al.  Regeneration of Osteonecrosis of Canine Scapho-lunate Using Bone Marrow Stromal Cells: Possible Therapeutic Approach for Kienböck Disease , 2006, Cell transplantation.

[8]  Younghun Jung,et al.  Regulation of SDF-1 (CXCL12) production by osteoblasts; a possible mechanism for stem cell homing. , 2006, Bone.

[9]  Xiaodan Yu,et al.  In Vitro Characteristics and In Vivo Immunosuppressive Activity of Compact Bone‐Derived Murine Mesenchymal Progenitor Cells , 2006, Stem cells.

[10]  T. Kipps,et al.  CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. , 2006, Blood.

[11]  Eleftherios Tsiridis,et al.  Bone substitutes: an update. , 2005, Injury.

[12]  G. Bianchi,et al.  The use of massive bone allografts in bone tumour surgery of the limb , 2005 .

[13]  A. Nagler,et al.  Chemokine receptor CXCR4–dependent internalization and resecretion of functional chemokine SDF-1 by bone marrow endothelial and stromal cells , 2005, Nature Immunology.

[14]  F Beaujean,et al.  Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. , 2005, The Journal of bone and joint surgery. American volume.

[15]  T. Lapidot,et al.  Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells. , 2005, Blood.

[16]  F. Tögel,et al.  Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury. , 2005, Kidney international.

[17]  A. Sun,et al.  Time course of myocardial stromal cell–derived factor 1 expression and beneficial effects of intravenously administered bone marrow stem cells in rats with experimental myocardial infarction , 2005, Basic Research in Cardiology.

[18]  Hiromu Ito,et al.  Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy , 2005, Nature Medicine.

[19]  Yan Huang,et al.  Stromal Cell–Derived Factor-1α Plays a Critical Role in Stem Cell Recruitment to the Heart After Myocardial Infarction but Is Not Sufficient to Induce Homing in the Absence of Injury , 2004, Circulation.

[20]  Abraham Schneider,et al.  Skeletal Localization and Neutralization of the SDF‐1(CXCL12)/CXCR4 Axis Blocks Prostate Cancer Metastasis and Growth in Osseous Sites In Vivo , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[21]  I. Bellantuono,et al.  A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. , 2004, Blood.

[22]  Frank McCormick,et al.  Activation of the hedgehog pathway in advanced prostate cancer , 2004, Molecular Cancer.

[23]  Geoffrey C Gurtner,et al.  Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 , 2004, Nature Medicine.

[24]  A. Otaka,et al.  Identification of a CXCR4 antagonist, a T140 analog, as an anti‐rheumatoid arthritis agent , 2004, FEBS letters.

[25]  S. T. Dheen,et al.  Interactions of Chemokines and Chemokine Receptors Mediate the Migration of Mesenchymal Stem Cells to the Impaired Site in the Brain After Hypoglossal Nerve Injury , 2004, Stem cells.

[26]  M. Imamura,et al.  CXCR4 antagonist inhibits stromal cell-derived factor 1-induced migration and invasion of human pancreatic cancer. , 2004, Molecular cancer therapeutics.

[27]  D. Krause,et al.  Plasticity of marrow-derived stem cells. , 2003, Blood.

[28]  J. Trent,et al.  Synthesis of potent CXCR4 inhibitors possessing low cytotoxicity and improved biostability based on T140 derivatives. , 2003, Organic & biomolecular chemistry.

[29]  M. Vingron,et al.  Gene expression profile of mouse bone marrow stromal cells determined by cDNA microarray analysis , 2003, Cell and Tissue Research.

[30]  M. Corr,et al.  Annals of the Rheumatic Diseases redesign , 2002, Annals of the rheumatic diseases.

[31]  T. Wilkinson,et al.  Hip fracture mortality and morbidity--can we do better? , 2001, The New Zealand medical journal.

[32]  M. Le Bousse-Kerdilès,et al.  Chemokine SDF-1 enhances circulating CD34(+) cell proliferation in synergy with cytokines: possible role in progenitor survival. , 2000, Blood.

[33]  S. Goldring,et al.  Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications , 1999, Arthritis research.

[34]  R. Bronson,et al.  Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. Sodroski,et al.  The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry , 1996, Nature.

[36]  Paul E. Kennedy,et al.  HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor , 1996, Science.

[37]  H. Kikutani,et al.  Molecular cloning and structure of a pre-B-cell growth-stimulating factor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[38]  T. Honjo,et al.  Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins. , 1993, Science.

[39]  Amy L Lerner,et al.  Micro-computed tomography prediction of biomechanical strength in murine structural bone grafts. , 2007, Journal of biomechanics.

[40]  Hung Li,et al.  Homing genes, cell therapy and stroke. , 2006, Frontiers in bioscience : a journal and virtual library.

[41]  M. Ratajczak,et al.  Tissue-specific muscle, neural and liver stem/progenitor cells reside in the bone marrow, respond to an SDF-1 gradient and are mobilized into peripheral blood during stress and tissue injury. , 2004, Blood cells, molecules & diseases.